Assembly Biosciences (ASMB) Change in Acquisitions & Divestments (2015 - 2026)

Assembly Biosciences' Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $57.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 117.92% year-over-year to $57.6 million; the TTM figure through Mar 2026 stood at $147.6 million (up 8.42% YoY), while the FY2025 annual figure was $116.4 million, down 10.92% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $57.6 million, up from $32.8 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $57.6 million in Q1 2026, with the low at -$37.2 million in Q4 2022.
• The 5-year median for Change in Acquisitions & Divestments is $22.7 million (2025), against an average of $23.4 million.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 186.45% in 2022, then soared 150.3% in 2023.
• Assembly Biosciences' Change in Acquisitions & Divestments stood at -$37.2 million in 2022, then jumped by 150.3% to $18.7 million in 2023, then soared by 82.89% to $34.2 million in 2024, then decreased by 4.09% to $32.8 million in 2025, then jumped by 75.61% to $57.6 million in 2026.
• Business Quant data shows ASMB's Change in Acquisitions & Divestments at $57.6 million in Q1 2026, $32.8 million in Q4 2025, and $22.7 million in Q3 2025.